Investors hammer Arena shares over new diet-pill uncertainty
Saturday, January 29th, 2011Area Pharmaceuticals co-founders Dominic Behan (leftover) and Jack Fain held tablets of the accompany’s weight-loss dose lorcaserin.
Investors sent shares of Domain Pharmaceuticals into a spin Friday astern the San Diego drugmaker aforementioned federal regulators deficiency more studies of its observational dieting tab lorcaserin, cast more dubiousness on the therapy’s chances of qualification it to commercialise.



